21 May 2013
Keywords: safinamide, enters, ph, iii, settle, trial, germany
Article | 11 May 2009
Germany's Merck KGaA and Italian drugmaker Newron Pharmaceuticals have initiated the SETTLE study, a late-stage trial that will evaluate the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 May 2009
13 May 2009
20 May 2013
© 2013 thepharmaletter.com